Stability of nanosuspensions in drug delivery

Journal of Controlled Release

Volumn 172, Issue 3, 2013, Pages 1126-1141

  Wang, Yancai ^a,b   Zheng, Ying ^b   Zhang, Ling ^c   Wang, Qiwei ^d   Zhang, Dianrui ^d  

^a SHANDONG POLYTECHNIC UNIVERSITY   (China)

^b University of Macau   (Macao)

^c SHANDONG UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Aggregation; Crystalline transformation; Nanosuspensions; Stability; Stabilizers

Indexed keywords

AGGLOMERATION; CONTROLLED DRUG DELIVERY; CONVERGENCE OF NUMERICAL METHODS; EMPENNAGES; FREE ENERGY; GIBBS FREE ENERGY; INDUSTRIAL RESEARCH; TARGETED DRUG DELIVERY;

COLLOIDAL DISPERSION; CRYSTALLINE TRANSFORMATION; EMPIRICAL RELATIONSHIPS; GIBBS FREE ENERGY CHANGES; NANO-SUSPENSIONS; OPERATIONAL PARAMETERS; STATE OF THE ART; TRIAL-AND-ERROR APPROACH;

STABILITY;

ANTHRACENE; BUPARVAQUONE; CELECOXIB; CYCLOSPORIN A; GLIBENCLAMIDE; HYDROCORTISONE ACETATE; IBUPROFEN; ITRACONAZOLE; NANOCRYSTAL; NAPROXEN; NIFEDIPINE; NITRENDIPINE; OMEPRAZOLE; PACLITAXEL; POLYMER; PREDNISOLONE ACETATE; PYRIMETHAMINE; STABILIZING AGENT;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; ENTHALPY; FLOCCULATION; FREEZE DRYING; HYDROGEL; HYDROPHOBICITY; NANOSUSPENSION; PARTICLE SIZE; PH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; SEDIMENTATION; SPRAY DRYING; SURFACE PROPERTY; SUSPENSION; TEMPERATURE; ZETA POTENTIAL;

AGGREGATION; CRYSTALLINE TRANSFORMATION; NANOSUSPENSIONS; STABILITY; STABILIZERS;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; HUMANS; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS; SUSPENSIONS;

EID: 84887587729     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.08.006     Document Type: Review

References (114)

1. R.C. Nagarwal, R. Kumar, M. Dhanawat, N. Das, and J.K. Pandit Nanocrystal technology in the delivery of poorly soluble drugs: an overview Curr. Drug Deliv. 8 2011 398 406
2. K. Fuhrmann, M.A. Gauthier, and J.C. Leroux Crosslinkable polymers for nanocrystal stabilization J. Control. Release 148 2010 e12 e13
3. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
4. P. Kayaert, and G. Van den Mooter Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with naproxen and cinnarizine Eur. J. Pharm. Biopharm. 81 2012 650 656
5. D.D. Zheng, Y.C. Wang, D.R. Zhang, Z.P. Liu, C.X. Duan, L.J. Jia, F.H. Wang, Y. Liu, G.P. Liu, L.L. Hao, and Q. Zhang In vitro antitumor activity of silybin nanosuspension in PC-3 cells Cancer Lett. 307 2011 158 164
6. M.A. Kassem, A.A. Abdel Rahman, M.M. Ghorab, M.B. Ahmed, and R.M. Khalil Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs Int. J. Pharm. 340 2007 126 133
7. R. Shegokar, and R.H. Muller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
8. S. Das, and P.K. Suresh Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B Nanomedicine 7 2011 242 247
9. E.L. Barle, M. Cerne, L. Peternel, and M. Homar Reduced intravenous toxicity of amiodarone nanosuspension in mice and rats Drug Chem. Toxicol. 36 2013 263 269
10. J. McKee, B. Rabinow, C. Cook, and J. Gass Nanosuspension formulation of itraconazole eliminates the negative inotropic effect of SPORANOX in dogs J. Med. Toxicol. 6 2010 331 336
11. F. Liu, J.Y. Park, Y. Zhang, C. Conwell, Y. Liu, S.R. Bathula, and L. Huang Targeted cancer therapy with novel high drug-loading nanocrystals J. Pharm. Sci. 99 2010 3542 3551
12. A. Dolenc, J. Kristl, S. Baumgartner, and O. Planinsek Advantages of celecoxib nanosuspension formulation and transformation into tablets Int. J. Pharm. 376 2009 204 212
13. L. Gao, D. Zhang, M. Chen, T. Zheng, and S. Wang Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement Drug Dev. Ind. Pharm. 33 2007 1332 1339
14. S. Dodiya, S. Chavhan, A. Korde, and K.K. Sawant Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies Drug Dev. Ind. Pharm. 39 2013 733 743
15. X. Li, L. Gu, Y. Xu, and Y. Wang Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats Drug Dev. Ind. Pharm. 35 2009 827 833
16. I. Ghosh, D. Schenck, S. Bose, and C. Ruegger Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of vitamin E TPGS and nanocrystal particle size on oral absorption Eur. J. Pharm. Sci. 47 2012 718 728
17. W. Sun, S.R. Mao, Y. Shi, L.C. Li, and L. Fang Nanonization of Itraconazole by High Pressure Homogenization: stabilizer Optimization and Effect of Particle Size on Oral Absorption J. Pharm. Sci. 100 2011 3365 3373
18. J. Lee, S.J. Lee, J.Y. Choi, J.Y. Yoo, and C.H. Ahn Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion Eur. J. Pharm. Sci. 24 2005 441 449
19. S. Verma, B.D. Huey, and D.J. Burgess Scanning probe microscopy method for nanosuspension stabilizer selection Langmuir 25 2009 12481 12487
20. H.Y. Lou, L. Gao, X.B. Wei, Z. Zhang, D.D. Zheng, D.R. Zhang, X.M. Zhang, Y. Li, and Q. Zhang Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice Colloids Surf. B 87 2011 319 325
21. V. Teeranachaideekul, V.B. Junyaprasert, E.B. Souto, and R.H. Muller Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology Int. J. Pharm. 354 2008 227 234
22. L. Gao, G.Y. Liu, J.L. Ma, X.Q. Wang, L. Zhou, and X. Li Drug nanocrystals: in vivo performances J. Control. Release 160 2012 418 430
23. Y.C. Wang, Y.Y. Ma, Y. Zheng, J. Song, X. Yang, C. Bi, D.R. Zhang, and Q. Zhang In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity Int. J. Pharm. 441 2013 728 735
24. H. Rachmawati, L. Al Shaal, R.H. Muller, and C.M. Keck Development of curcumin nanocrystal: physical aspects J. Pharm. Sci. 102 2013 204 214
25. H.S. Ali, P. York, and N. Blagden Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors Int. J. Pharm. 375 2009 107 113
26. J. Hu, W.K. Ng, Y.C. Dong, S.C. Shen, and R.B.H. Tan Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying Int. J. Pharm. 404 2011 198 204
27. I. Ghosh, S. Bose, R. Vippagunta, and F. Harmon Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth Int. J. Pharm. 409 2011 260 268
28. J. Moschwitzer, G. Achleitner, H. Pomper, and R.H. Muller Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology Eur. J. Pharm. Biopharm. 58 2004 615 619
29. D. Xia, P. Quan, H. Piao, S. Sun, Y. Yin, and F. Cui Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability Eur. J. Pharm. Sci. 40 2010 325 334
30. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840
31. D. Xia, M. Ouyang, J.X. Wu, Y. Jiang, H. Piao, S. Sun, L. Zheng, J. Rantanen, F. Cui, and M. Yang Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism Pharm. Res. 29 2012 158 169
32. C. Detroja, S. Chavhan, and K. Sawant Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study Sci. Pharm. 79 2011 635 651
33. Y.A. Gao, S.A. Qian, and J.J. Zhang Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension Chem. Pharm. Bull. 58 2010 912 917
34. Y. Gao, Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, J. Cui, H. Lou, and G. Zhai Preparation and characterization of intravenously injectable curcumin nanosuspension Drug Deliv. 18 2011 131 142
35. J.H. Kim, S.W. Jang, S.D. Han, H.D. Hwang, and H.G. Choi Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods Pharmazie 66 2011 491 495
36. M. Aghajani, A.R. Shahverdi, S.M. Rezayat, M.A. Amini, and A. Amani Preparation and optimization of acetaminophen nanosuspension through nanoprecipitation using microfluidic devices: an artificial neural networks study Pharm. Dev. Technol. 18 2013 609 618
37. M.S. Nasser, F.A. Twaiq, and S.A. Onaizi Effect of polyelectrolytes on the degree of flocculation of papermaking suspensions Sep. Purif. Technol. 103 2013 43 52
38. S. Barany, and A. Szepesszentgyorgyi Flocculation of cellular suspensions by polyelectrolytes Adv. Colloid Interface Sci. 111 2004 117 129
39. B. Van Eerdenbrugh, B. Stuyven, L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter Downscaling drug nanosuspension production: processing aspects and physicochemical characterization Aaps Pharmscitech 10 2009 44 53
40. X. Chen, M.E. Matteucci, C.Y. Lo, K.P. Johnston, and R.O. Williams 3rd Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders Drug Dev. Ind. Pharm. 35 2009 283 296
41. D.S. Singare, S. Marella, K. Gowthamrajan, G.T. Kulkarni, R. Vooturi, and P.S. Rao Optimization of formulation and process variable of nanosuspension: an industrial perspective Int. J. Pharm. 402 2010 213 220
42. B. Van Eerdenbrugh, L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van Den Mooter Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion Eur. J. Pharm. Sci. 35 2008 344 353
43. S. Bose, D. Schenck, I. Ghosh, A. Hollywood, E. Maulit, and C. Ruegger Application of spray granulation for conversion of a nanosuspension into a dry powder form Eur. J. Pharm. Sci. 47 2012 35 43
44. K. Nakamoto, T. Urasaki, S. Hondo, N. Murahashi, E. Yonemochi, and K. Terada Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging J. Pharmaceut. Biomed. Anal. 75 2013 105 111
45. V. Puri, A.K. Dantuluri, M. Kumar, N. Karar, and A.K. Bansal Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug Eur. J. Pharm. Sci. 40 2010 84 93
46. A.B. da Fonseca Antunes, B.G. De Geest, C. Vervaet, and J.P. Remon Solvent-free drug crystal engineering for drug nano- and micro suspensions Eur. J. Pharm. Sci. 48 2013 121 129
47. M.J. Davies, L. Seton, N. Tiernan, M.F. Murphy, and P. Gibbons Towards crystal engineering via simulated pulmonary surfactant monolayers to optimise inhaled drug delivery Int. J. Pharm. 421 2011 1 11
48. C. Brough, and R.O. Williams III Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery Int. J. Pharm. 453 2013 157 166
49. H. de Waard, W.L.J. Hinrichs, and H.W. Frijlink A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying J. Control. Release 128 2008 179 183
50. G. Shen, Q. Wang, Q. Zhang, H. Sun, Y. Zhao, Z. Zhang, and B. Du Tissue distribution of 2-methoxyestradiol nanosuspension in rats and its antitumor activity in C57BL/6 mice bearing Lewis lung carcinoma Drug Deliv. 19 2012 327 333
51. S. Du, L. Zhu, B. Du, X. Shi, Z. Zhang, S. Wang, and C. Zhang Pharmacokinetic evaluation and antitumor activity of 2-methoxyestradiol nanosuspension Drug Dev. Ind. Pharm. 38 2012 431 438
52. P. Aramwit, T. Kerdcharoen, and H. Qi In vitro plasma compatibility study of a nanosuspension formulation PDA J. Pharm. Sci. Technol. 60 2006 211 217
53. L.B. Wu, J. Zhang, and W. Watanabe Physical and chemical stability of drug nanoparticles Adv. Drug Deliv. Rev. 63 2011 456 469
54. S.S. Dodiya, S.S. Chavhan, K.K. Sawant, and A.G. Korde Solid lipid nanoparticles and nanosuspension formulation of saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies J. Microencapsul. 28 2011 515 527
55. R.H. Muller, and C. Jacobs Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability Int. J. Pharm. 237 2002 151 161
56. L. Gao, G. Liu, X. Wang, F. Liu, Y. Xu, and J. Ma Preparation of a chemically stable quercetin formulation using nanosuspension technology Int. J. Pharm. 404 2011 231 237
57. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
58. S.K. Singh, K.K. Srinivasan, K. Gowthamarajan, D.S. Singare, D. Prakash, and N.B. Gaikwad Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide Eur. J. Pharm. Biopharm. 78 2011 441 446
59. B. Van Eerdenbrugh, S. Vercruysse, J.A. Martens, J. Vermant, L. Froyen, J. Van Humbeeck, G. Van den Mooter, and P. Augustijns Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole Eur. J. Pharm. Biopharm. 70 2008 590 596
60. Y.L. Wang, X.M. Li, L.Y. Wang, Y.L. Xu, X.D. Cheng, and P. Wei Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery Int. J. Nanomedicine 6 2011 1497 1507
61. K.A. Mahmoud, J.A. Mena, K.B. Male, S. Hrapovic, A. Kamen, and J.H.T. Luong Effect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystals ACS Appl. Mater. Interfaces 2 2010 2924 2932
62. V. Dhapte, and V. Pokharkar Polyelectrolyte stabilized antimalarial nanosuspension using factorial design approach J. Biomed. Nanotechnol. 7 2011 139 141
63. P. Quan, K. Shi, H.Z. Piao, H.Y. Piao, N. Liang, D.N. Xia, and F.D. Cui A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability Int. J. Pharm. 430 2012 366 371
64. P. Sharma, and S. Garg Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs Adv. Drug Deliv. Rev. 62 2010 491 502
65. J.Y. Choi, J.Y. Yoo, H.S. Kwak, B.U. Nam, and J. Lee Role of polymeric stabilizers for drug nanocrystal dispersions Cur. Appl. Phys. 5 2005 472 474
66. X.Y. Xiong, K.C. Tam, and L.H. Gan Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles J. Control. Release 108 2005 263 270
67. P.C. Chiang, Y. Ran, K.J. Chou, Y. Cui, and H. Wong Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery Nanoscale Res. Lett. 6 2011 413
68. P.N. Ezhilarasi, P. Karthik, N. Chhanwal, and C. Anandharamakrishnan Nanoencapsulation techniques for food bioactive components: a review Food Bioprocess Technol. 6 2013 628 647
69. E. Bouyer, G. Mekhloufi, V. Rosilio, J.L. Grossiord, and F. Agnely Proteins, polysaccharides, and their complexes used as stabilizers for emulsions: alternatives to synthetic surfactants in the pharmaceutical field? Int. J. Pharm. 436 2012 359 378
70. W. He, Y. Lu, J.P. Qi, L.Y. Chen, F.Q. Hu, and W. Wu Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs Int. J. Pharm. 441 2013 269 278
71. M. George, and I. Ghosh Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology Eur. J. Pharm. Sci. 48 2013 142 152
72. J. Siepmann, and N.A. Peppas Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv. Drug Deliv. Rev. 64 2012 163 174
73. X.C. Fu, G.P. Wang, W.Q. Liang, and M.S.S. Chow Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration J. Control. Release 95 2004 209 216
74. M. Nakarani, P. Patel, J. Patel, R.S. Murthy, and S.S. Vaghani Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation Sci. Pharm. 78 2010 345 361
75. C.L. Lo, S.J. Lin, H.C. Tsai, W.H. Chan, C.H. Tsai, C.H. Cheng, and G.H. Hsiue Mixed micelle systems formed from critical micelle concentration and temperature-sensitive diblock copolymers for doxorubicin delivery Biomaterials 30 2009 3961 3970
76. H. Wang, Q. Pan, and G.L. Rempel Micellar nucleation differential microemulsion polymerization Eur. Polym. J. 47 2011 973 980
77. J.X. Deng, L. Huang, and F. Liu Understanding the structure and stability of paclitaxel nanocrystals Int. J. Pharm. 390 2010 242 249
78. F. Kesisoglou, S. Panmai, and Y.H. Wu Nanosizing - oral formulation development and biopharmaceutical evaluation Adv. Drug Deliv. Rev. 59 2007 631 644
79. M. Milewski, T.R. Yerramreddy, P. Ghosh, P.A. Crooks, and A.L. Stinchcomb In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin J. Control. Release 146 2010 37 44
80. M. Kakran, R. Shegokar, N.G. Sahoo, S. Gohla, L. Li, and R.H. Muller Long-term stability of quercetin nanocrystals prepared by different methods J. Pharm. Pharmacol. 64 2012 1394 1402
81. H.K. Valo, P.H. Laaksonen, L.J. Peltonen, M.B. Linder, J.T. Hirvonen, and T.J. Laaksonen Multifunctional hydrophobin: toward functional coatings for drug nanoparticles Acs Nano 4 2010 1750 1758
82. S. Verma, R. Gokhale, and D.J. Burgess A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions Int. J. Pharm. 380 2009 216 222
83. Y.C. Wang, Z.P. Liu, D.R. Zhang, X.H. Gao, X.Y. Zhang, C.X. Duan, L.J. Jia, F.F. Feng, Y.J. Huang, Y.M. Shen, and Q.A. Zhang Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension Colloids Surf. B 83 2011 189 197
84. H.Y. Li, P.C. Seville, I.J. Williamson, and J.C. Birchall Dispersibility of spray-dried formulations for pulmonary drug delivery J. Pharm. Pharmacol. 56 2004 S9 S10
85. Y.C. Wang, D.R. Zhang, Z.P. Liu, G.P. Liu, C.X. Duan, L.J. Jia, F.F. Feng, X.Y. Zhang, Y.Q. Shi, and Q. Zhang In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery Nanotechnology 21 2010 155104
86. G.P. Liu, D.R. Zhang, Y. Jiao, D.D. Zheng, Y. Liu, C.X. Duan, L.J. Jia, Q. Zhang, and H.X. Lou Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology Int. J. Pharm. 422 2012 516 522
87. R.L. Xiong, W.G. Lu, J. Li, P.Q. Wang, R. Xu, and T.T. Chen Preparation and characterization of intravenously injectable nimodipine nanosuspension Int. J. Pharm. 350 2008 338 343
88. M. Sun, Y. Gao, Y. Pei, C. Guo, H. Li, F. Cao, A. Yu, and G. Zhai Development of nanosuspension formulation for oral delivery of quercetin J. Biomed. Nanotechnol. 6 2010 325 332
89. P. Sharma, Z.D. Zujovic, G.A. Bowmaker, A.J. Marshall, W.A. Denny, and S. Garg Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies Int. J. Pharm. 408 2011 138 151
90. J. Salazar, O. Heinzerling, R.H. Muller, and J.P. Moschwitzer Process optimization of a novel production method for nanosuspensions using design of experiments (DoE) Int. J. Pharm. 420 2011 395 403
91. V. Joshi, S. Dwivedi, and G.H. Ward Increase in the specific surface area of budesonide during storage postmicronization Pharm. Res. 19 2002 7 12
92. S.Y. Tang, P. Shridharan, and M. Sivakumar Impact of process parameters in the generation of novel aspirin nanoemulsions - comparative studies between ultrasound cavitation and microfluidizer Ultrason. Sonochem. 20 2013 485 497
93. Y. Liu, D. Zhang, D. Zou, Y. Wang, C. Duan, L. Jia, P. Xie, F. Feng, F. Wang, X. Zhang, and Q. Zhang Development and in vitro characterizations of bifendate nanosuspension J. Biomed. Nanotechnol. 7 2011 1 11
94. L.L. Hao, X.Y. Wang, D.R. Zhang, Q.Y. Xu, S.Y. Song, F.H. Wang, C.Y. Li, H.J. Guo, Y. Liu, D.D. Zheng, and Q. Zhang Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals Int. J. Pharm. 433 2012 157 164
95. M. Kakran, N.G. Sahoo, L. Li, Z. Judeh, Y. Wang, K. Chong, and L. Loh Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension Int. J. Pharm. 383 2010 285 292
96. M. Kakran, N.G. Sahoo, L. Li, Z. Judeh, and P. Panda Artemisinin- polyvinylpyrrolidone composites prepared by evaporative precipitation of nanosuspension for dissolution enhancement J. Biomater. Sci. Polym. Ed. 22 2011 363 378
97. M. Ahuja, A.S. Dhake, S.K. Sharma, and D.K. Majumdar Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery J. Microencapsul. 28 2011 37 45
98. P.C. Chiang, J.W. Alsup, Y. Lai, Y. Hu, B.R. Heyde, and D. Tung Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery Nanoscale Res. Lett. 4 2009 254 261
99. B. Stark, G. Pabst, and R. Prassl Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structure Eur. J. Pharm. Sci. 41 2010 546 555
100. J. Lee Drug nano- and microparticles processed into solid dosage forms: physical properties J. Pharm. Sci. 92 2003 2057 2068
101. T. Niwa, S. Miura, and K. Danjo Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs Pharm. Res. 28 2011 2339 2349
102. M. Mezhericher, M. Naumann, M. Peglow, A. Levy, E. Tsotsas, and I. Borde Continuous species transport and population balance models for first drying stage of nanosuspension droplets Chem. Eng. J. 210 2012 120 135
103. H. Ho, and J. Lee Redispersible drug nanoparticles prepared without dispersant by electro-spray drying Drug Dev. Ind. Pharm. 38 2012 744 751
104. A. Bohr, M.S. Yang, S. Baldursdottir, J. Kristensen, M. Dyas, E. Stride, and M. Edirisinghe Particle formation and characteristics of celecoxib-loaded poly(lactic-co-glycolic acid) microparticles prepared in different solvents using electrospraying Polymer 53 2012 3220 3229
105. H.K. Chan, and P.C.L. Kwok Production methods for nanodrug particles using the bottom-up approach Adv. Drug Deliv. Rev. 63 2011 406 416
106. H. Ho, and J. Lee PEG/PLA Core/shell particles from coaxial electrohydrodynamic spray drying Macromol. Res. 19 2011 815 821
107. B. Van Eerdenbrugh, L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter Drying of crystalline drug nanosuspensions - the importance of surface hydrophobicity on dissolution behavior upon redispersion Eur. J. Pharm. Sci. 35 2008 127 135
108. L. Zhang, L. Liu, Y. Qian, and Y. Chen The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM) Eur. J. Pharm. Biopharm. 69 2008 750 759
109. R. Mauludin, R.H. Muller, and C.M. Keck Kinetic solubility and dissolution velocity of rutin nanocrystals Eur. J. Pharm. Sci. 36 2009 502 510
110. R. Mauludin, R.H. Muller, and C.M. Keck Development of an oral rutin nanocrystal formulation Int. J. Pharm. 370 2009 202 209
111. N. Chung, M.K. Lee, and J. Lee Mechanism of freeze-drying drug nanosuspensions Adv. Int. J. Pharm. 437 2012 42 50
112. J. Lee, and Y. Cheng Critical freezing rate in freeze drying nanocrystal dispersions J. Control. Release 111 2006 185 192
113. M.K. Lee, M.Y. Kim, S. Kim, and J. Lee Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate J. Pharm. Sci. 98 2009 4808 4817
114. S. Gupta, M.K. Samanta, and A.M. Raichur Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy Aaps Pharmscitech 11 2010 322 335